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ObituaryEli E. Sercarz (1934–2009)Photograph of Eli E. Sercarz.We are sad to inform the scientific com-
munity of the death of Eli Sercarz in
Topanga Canyon, California, on Novem-
ber 3rd, 2009. After receiving a Ph.D.
from Harvard in 1960 and doing postdoc-
toral work at Harvard and MIT, Eli had
a career of more than 45 years as an inde-
pendent investigator, including 37 years
on the faculty of UCLA, followed by stints
at the La Jolla Institute for Allergy and
Immunology (1997–2002) and at the Tor-
rey Pines Institute for Molecular Studies
(TPIMS). Although Eli had been suffering
from renal cancer for several years, he
remained active at TPIMS until his death,
with ongoing NIH-funded projects and
manuscripts in preparation, as well as
lectures at international meetings, as
recently as last October. Eli and his col-
leagues made major contributions to our
understanding of antigen presentation,
immune regulation, tolerance, and auto-
immunity. Research in each area was
anchored by a focus on the generation
of peptidic epitopes for presentation to
T cells, and they imprinted these fields
with a unique vocabulary, reflecting a
research program that was both idiosyn-
cratic and innovative.
Eli’s research career featured a number
of seminal contributions that helped
shape immunology, which was just devel-
oping when he entered the field. Starting
in the 1960s, his lab was among the first
to study the T and B cell response to
protein antigens. Using the tools available
at that time (i.e., before recombinant DNA
and synthetic peptide technologies), he
published a landmark series of studies
on the antigenic structure of the protease
lysozyme that helped define the specific
regions of this protein that were the focus
of the T cell response in different mouse
strains. These early observations formed
the basis for the major questions that
would occupy the rest of his career, which
centered on understanding which anti-
genic determinants within a protein were
selected by the immune system as the
targets of the T cell response and on char-
acterizing the pathways and mechanisms
that controlled this process. During
the course of these studies, Eli showed
that a hierarchy of responsiveness could
be demonstrated for different antigenicdeterminants within a single protein, with
some peptides eliciting the greatest
response magnitude (‘‘immunodomi-
nant’’). Others still capable of major histo-
compatibility complex (MHC) binding
either were the targets of a quantitatively
smaller response (‘‘subdominant’’) or
were ignored in the context of the intact
antigen, despite the presence of a T cell
repertoire capable of recognizing them
(‘‘cryptic’’). He further demonstrated that
these concepts, developed from immuni-
zation studies, could also be applied to
the response to self-antigens, with immu-
nodominant antigens likely to induce
deletional tolerance, leaving the subdom-
inant and cryptic epitopes as the targets
of self-reactive T cells. These ideas have
had a guiding influence on understanding
T cell responses in infectious disease,
cancer, and autoimmunity.
The role of determinant hierarchy in
self-reactivity became a major theme in
Eli’s research, and he began working to
elucidate how epitope selection could
guide the course of autoimmune disease.
Working in animal models ofmultiple scle-
rosis (experimental autoimmune enceph-
alomyelitis) and arthritis (collagen-
induced arthritis), his lab showed thatImmunity 31, Dan autoimmune response initiated to a
specific immunodominant epitope could
develop over time to include other deter-
minants within the same antigen (‘‘intra-
molecular determinant spreading’’) or to
other proteins expressed within the
same target cell or tissue (‘‘intermolecular
determinant spreading’’). He later showed
that this determinant spreading can be
promulgated by a specific T cell clone
against an immunodominant peptide
(called the ‘‘driver clone’’) and that dis-
ease resolution can involve a regulatory
response against idiotypic determinants
of the TCR expressed by the driver clone.
These findings have had a far-reaching
impact on our understanding of autoim-
munity, and evidence for determinant
spreading has been found in the immune
response to human cancer. Additionally,
Eli maintained an avid interest in under-
standing the molecular regulation of
immunodominance and crypticity,making
key contributions to understanding how
MHC molecules guide the processing
of proteins to peptides, how different
antigen-presenting cells produce and
present distinct determinants from the
same source antigen, and how neonatal
tolerance is caused by clonal deletion.
These achievements reflect the breadth
and depth of Eli’s insouciant curiosity
and formidable intellect.
Although born in the Bronx, much of
Eli’s life was rooted in Southern California.
As a youth, in order to help him recover
from rheumatic fever, his mother took
him to live in a health spa in Tecate,
Mexico. While there, Eli would ride his
bike across the border to attend high
school in San Diego County, and he later
attended San Diego State College. As an
adult, he and his wife, Rabyn, enjoyed
the bucolic ambience of Topanga Can-
yon, known to inspire artistic creativity
from the likes of Woody Guthrie, Joni
Mitchell, and many others.
For Eli Sercarz, the aspects of playful-
ness and enjoyment were never far
removed from the intensity and effort of
research. You could count on the fact
that detailed discussions in his group
meeting, ‘‘data circus’’ in the lab lexicon,
and journal club would be accompanied
by good food, particularly flavorfulecember 18, 2009 ª2009 Elsevier Inc. 845
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Obituarycheeses, fresh bagels or pastries, and
sometimes wine (in the afternoon). Eli’s
love of dancing and travel to scientific
meetings were legendary, and he main-
tained close contacts with colleagues
around the world. Although the competi-
tion and stress of modern biomedical
research were unpleasant facts to be
acknowledged, in Eli’s view success is
not zero sum game, and an individual’s
accomplishments should not come at
the expense of another. With his highly846 Immunity 31, December 18, 2009 ª2009sympathetic character, Eli rarely had
a negative word to say about colleagues
or competitors.
The stimulating and nurturing atmo-
sphere in the Sercarz group was fueled
by Eli’s concern for his trainees as people
and as scientists, and his utter respect
for the ideas of everyone in the group,
neophytes as well as seasoned veterans.
It is therefore appropriate that in addition
to his other awards, Eli Sercarz received
the Excellence in Mentoring Award fromElsevier Inc.the American Association of Immunolo-
gists in 2007. In addition to his many for-
mer trainees, his many good colleagues,
who can be found on nearly every conti-
nent, will also deeply miss Eli.
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